“Entrepreneurs for Entrepreneurs” IMAGINE IF! Idea Competition OXFORD PITCHING FINAL Are you interested in what 10 teams of Oxford science entrepreneurs have identified as problems and needs? And how they went about addressing them by applying their science and expertise? Join us on Thursday 12th October 2017 at 18:00, at the Centenary Room, Careers Serviceaaa

LAB282 is a new funding partnership in Oxford, which has just awarded its first grants. We interviewed Dr Thomas Hanke, Expert in Residence at LAB282 and Head of Academic Partnerships at Evotec. Read on to find out what is so unique about LAB282, what it can offer and, most importantly, how to get them toaaa

Fostering Pharma collaborations, securing grants for innovation and investment opportunities to innovate in the University setting The University of Oxford 2013-2018 strategic plan starts with the vision to lead in research and education and foster a culture in which innovation plays an important role, with the ultimate goal to benefit society on a national andaaa

It is no accident that the University of Oxford ranked first in the latest Times Higher Education World University Rankings, reflecting its all-round strength in teaching, research and general impact. One of the major performance indicators that secured the top place is Industry Income, where knowledge-transfer activities and industry engagement were demonstrated brilliantly, with Oxford Universityaaa

Oxford University and Evotec’s drug discovery partnership launched last November to accelerate drugs to market begins making awards. Hamburg, Germany, 21 February 2017: Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) is pleased to announce that LAB282, the £13m drug discovery partnership with Oxford University, has made its first wave of awards, backing projectsaaa